The development of stereotactic body radiotherapy in the past decade: a global perspective

Author:

Lo Simon S1,Slotman Ben J2,Lock Michael3,Nagata Yasushi4,Guckenberger Matthias5,Siva Shankar6,Foote Matthew7,Tan Daniel8,Teh Bin S9,Mayr Nina A10,Chang Eric L11,Timmerman Robert D12,Sahgal Arjun13

Affiliation:

1. Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, OH, USA

2. Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands

3. Department of Radiation Oncology, London Regional Cancer Program, University of Western Ontario, London, ON, Canada

4. Department of Radiation Oncology, Hiroshima University, Hiroshima, Japan

5. Department of Radiation Oncology, University of Zurich, Zurich, Switzerland

6. Division of Radiation Oncology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia

7. Department of Radiation Oncology, Princess Alexandra Hospital, School of Medicine, University of Queensland, Queensland, Australia

8. Asian American Radiation Oncology, Singapore

9. Department of Radiation Oncology, Houston Methodist Hospital, Weill Cornell Medical College, Houston, TX, USA

10. Department of Radiation Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

11. Department of Radiation Oncology, Keck School of Medicine & Norris Cancer Center at the University of Southern California, Los Angeles, CA, USA

12. Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA

13. Department of Radiation Oncology, Sunnybrook Health Sciences Center, University of Toronto, Toronto, ON, Canada

Abstract

In the past 10 years, there has been an exponential increase in the incorporation of stereotactic body radiotherapy, also known as stereotactic ablative radiotherapy, into the armamentarium against various types of cancer in different settings worldwide. In this article in the 10th year anniversary issue of Future Oncology, representatives from the USA, Canada, Japan, Germany, The Netherlands, Australia and Singapore will provide individual perspectives of the development of stereotactic body radiotherapy in their respective countries.

Publisher

Future Medicine Ltd

Subject

Cancer Research,Oncology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3